Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 101kWORD 17k
31 May 2018
E-002999-18
Question for written answer E-002999-18
to the Commission
Rule 130
Roberta Metsola (PPE)

 Subject:  Use of real-world data for medical research
 Answer in writing 

EU Health Commissioner Vytenis Andriukaitis said on 26 January 2018 that ‘big data, in particular, real-world data, holds enormous and obvious potential in the field of medical research’.

The Commissioner also added that ‘regarding the real world data, we will need to further explore the opportunities and limitations of its use for decision making on medicinal products and in the development of new products’.

Can the Commission provide more information on what measures will be taken to explore the opportunities and limitations of real-world data for medical research?

Last updated: 12 June 2018Legal notice - Privacy policy